Snapshot from Aug 16, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Telix H1 2026 Results Release
Business earnings announcement

Telix H1 2026 Results Release

Analysis based on 7 articles · First reported Jul 30, 2026 · Last updated Jul 31, 2026

Sentiment
0
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is a routine scheduling notice for Telix's half-year results, which may lead to modest trading activity as investors anticipate the financial disclosure. The market impact is expected to be limited until the actual results are released on August 20, 2026.

Pharmaceuticals Biotechnology
Event Summary

Telix Pharmaceuticals Limited announced that it will release its financial results for the half-year ended June 30, 2026 on Thursday, August 20, 2026. An investor webcast and conference call will be held at 9:00 a.m. AEST on the same day (7:00 p.m. EDT on Wednesday, August 19, 2026). The company, a commercial-stage global radiopharmaceutical company, highlighted its prostate cancer imaging portfolio, including Illuccix and Gozellix, and its late-stage therapeutic pipeline with three investigational assets in pivotal-stage trials. The announcement was authorized by the Company Secretary, Shomalin Naidoo.

Key Actions
100 Telix Pharmaceuticals announced results release
Entities Involved
stock
Telix Pharmaceuticals
Telix Pharmaceuticals is the central entity, announcing the date for its H1 2026 financial results release and investor webcast. The event is a routine corporate disclosure, with no immediate impact on its stock price.
Importance 100.0 Sentiment 0.0
exch
Australian Securities Exchange
The Australian Securities Exchange is the primary listing venue for Telix, where the results will be released. The event is routine and does not affect the exchange itself.
Importance 10.0 Sentiment 0.0
exch
Nasdaq
Nasdaq is the secondary listing venue for Telix, where the results will also be available. The event is routine and does not affect the exchange itself.
Importance 10.0 Sentiment 0.0
cnt
United States
The United States is a key market for Telix, where its products are commercially available and approved. The event is routine and does not affect the country.
Importance 5.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission is mentioned as a regulator where Telix files reports, including the Annual Report on Form 20-F. The event is routine and does not affect the SEC.
Importance 5.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration is mentioned as the approver of Gozellix, a product in Telix's portfolio. The event is routine and does not affect the FDA.
Importance 5.0 Sentiment 0.0
cnt
Australia
Australia is the home country of Telix, where the company is headquartered. The event is routine and does not affect the country.
Importance 5.0 Sentiment 0.0
Relationships
Australian Securities Exchange related ↔ Nasdaq
Australian Securities Exchange related ↔ Australia
Nasdaq related ↔ United States
Nasdaq regulated ↔ United States — United States Securities and Exchange Commission Nasdaq operates as a registered national securities exchange under the direct oversight and regulatory authority of the
Nasdaq related ↔ United States — Food and Drug Administration
Nasdaq related ↔ Australia
United States related ↔ United States — United States Securities and Exchange Commission
United States related ↔ United States — Food and Drug Administration
United States related ↔ Australia
United States — United States Securities and Exchange Commission related ↔ United States — Food and Drug Administration
United States — United States Securities and Exchange Commission related ↔ Australia
United States — Food and Drug Administration related ↔ Australia
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.